Recep BEKİS, Nazlı Pınar KARAHAN ŞEN, Bihter ŞENTÜRK, Bahri AKDENİZ
Molecular Imaging and Radionuclide Therapy
169-176
The Use of 18F-FDG PET/CT in Patients with Recurrent Differentiated Thyroid Cancer
Molecular Imaging and Radionuclide Therapy
The Relationship Between HER-2 Expression Levels and 18F-FDG PET/CT Parameters in Gastric Cancer
Molecular Imaging and Radionuclide Therapy
Seyit Ahmet ERTÜRK, Zekiye HASBEK, Hatice ÖZER
Prognostic Prediction of BRCA Mutations by 18F-FDG PET/CT SUV max in Breast Cancer
Molecular Imaging and Radionuclide Therapy
Semra ÖZDEMİR, Fatma SILAN, Mehmet Yılmaz AKGÜN, Nilgün ARACI, İsmail ÇIRPAN, Fulya Koç ÖZTÜRK, Öztürk ÖZDEMİR
Is SUV Corrected for Lean Body Mass Superior to SUV of Body Weight in 68Ga-PSMA PET/CT?
Molecular Imaging and Radionuclide Therapy
Molecular Imaging and Radionuclide Therapy
Mustafa EROL, Hasan ÖNNER, Meryem İlkay EREN KARANİS
Meme Kanserlerinde BRCA Mutasyonlarının 18F-FDG PET/BT SUVmax Değeri ile Prognostik Tahmini
Molecular Imaging and Radionuclide Therapy
Semra ÖZDEMİR, Fatma SILAN, Öztürk ÖZDEMİR, Mehmet Yılmaz AKGÜN, Nilgün ARACI, İsmail ÇIRPAN, Fulya Koç ÖZTÜRK
68Ga-FAPI Pozitif, 18F-FDG Negatif Meme Kanseri Olgusu
Molecular Imaging and Radionuclide Therapy
Canan CAN, Halil KOMEK, Cihan GÜNDOĞAN, Hülya ETEM
Polisitemi Vera Tanılı mCRPC Hastasında Radyum-223 Tedavisi
Molecular Imaging and Radionuclide Therapy
Giuseppe de VINCENTIS, Viviana FRANTELLIZZI, Mariano PONTİCO, Cristina de ANGELIS, Maria Silvia de FEO, Julia LAZRİ